NEW YORK ( TheStreet) -- DexCom (Nasdaq: DXCM) hit a new 52-week low Tuesday as it is currently trading at $7.32, below its previous 52-week low of $7.33 with 136,010 shares traded as of 10:40 a.m. ET. Average volume has been 656,900 shares over the past 30 days.

DexCom has a market cap of $515.1 million and is part of the health care sector and health services industry. Shares are down 44.1% year to date as of the close of trading on Monday.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.
  • Practice your DXCM trading strategies and win cash in our stock game.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full DexCom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.